Although SMARCD3 expression and function may not be exclusive to cancer stem cells alone, we found that Smarcd3 was a stem-inclusive dependency whose perturbation was sufficient to block the growth of pancreatic cancer stem cells in vivo. The gene discussed is SMARCD3; the disease is familial pancreatic carcinoma.